# OnCo record cellvax-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/cellvax-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "cellvax-therapeutics" ;
  schema:name "CellVax Therapeutics"@en ;
  schema:description "CellVax Therapeutics makes a personal vaccine from a man's own prostate cancer cells, taken at surgery, to train the immune system against any cancer left behind. It is being tested after prostate removal in men at higher risk of the cancer coming back."@en ;
  schema:url <https://onco.cc/companies/cellvax-therapeutics/>, <https://www.cellvx.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://www.cellvx.com/>, <https://clinicaltrials.gov/study/NCT06636682> ;
  schema:addressCountry "US" ;
  onco:related <https://onco.cc/companies/celldex/> ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/prostate-high-risk/> ;
  onco:sections <https://onco.cc/fronts/immunotherapy/> ;
  onco:trials <https://onco.cc/trials/nct06636682/> .
